Protection by Exclusion
- 24 April 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 136 (1) , 26-28
Abstract
Coronavirus disease 2019 (COVID-19) is a novel infectious disease that started in Wuhan, China, and has rapidly spread all across the world. With limited ability to contain the virus and relatively high transmissibility and case fatality rates, governmental institutions and pharmaceutical companies are racing to find therapeutics and vaccines that target this novel coronavirus. However, once again, pregnant and breastfeeding women are excluded from participating in clinical trials during this pandemic. This “protection by exclusion” of pregnant women from drug development and clinical therapeutic trials, even during epidemics and pandemics, is not unprecedented. Moreover, it is both misguided and not justifiable and may have excluded them from potentially beneficial interventions. This is another missed opportunity to obtain pregnancy-specific safety and efficacy data, because therapeutics developed for men and nonpregnant women may not be generalizable to pregnant women. Therefore, we recommend and urge the scientific community and professional societies that, without clear justification for exclusion, pregnant women should be given the opportunity to be included in clinical trials for COVID-19 based on the concepts of justice, equity, autonomy, and informed consent.Keywords
This publication has 7 references indexed in Scilit:
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Increasing the Participation of Pregnant Women in Clinical TrialsJAMA, 2018
- Protected to death: systematic exclusion of pregnant women from Ebola virus disease trialsReproductive Health, 2017
- Inclusion of pregnant and breastfeeding women in research – efforts and initiativesBritish Journal of Clinical Pharmacology, 2017
- Maternal fat free mass during pregnancy is associated with birth weightReproductive Health, 2017
- The pregnant women as a drug orphan: a global survey of registered clinical trials of pharmacological interventions in pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 2016
- Enrolling Pregnant Women: Issues in Clinical ResearchWomen's Health Issues, 2013